Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net loss	$ (55,582)	$ (70,858)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment	352	539
Amortization of platform development and intangible assets	27,354	26,570
Amortization of debt costs	2,378	1,581
Noncash and accrued interest	3,824	320
Loss on impairment of assets	119	466
Loss on sale of assets	325
Change in valuation of contingent consideration	1,010
Liquidated damages	583	1,140
Stock-based compensation	19,060	31,345
Deferred income taxes	134	(1,200)
Bad debt expense	315	658
Other		184
Change in operating assets and liabilities net of effect of acquisitions:
Accounts receivable	(11,599)	(2,038)
Subscription acquisition costs	3,143	(1,667)
Royalty fees		11,250
Prepayments and other current assets	(2,157)	2,280
Other long-term assets	(77)	(285)
Accounts payable	(2,663)	(6,535)
Accrued expenses and other	3,453	(2,996)
Unearned revenue	(7,970)	3,898
Subscription refund liability	(396)	(2,379)
Operating lease liability	(231)	(218)
Other long-term liabilities	(6,147)	(3,359)
Net cash used in operating activities	(24,772)	(11,304)
Cash flows from investing activities
Purchases of property and equipment		(530)
Capitalized platform development	(3,773)	(5,179)
Proceeds from sale of assets	1,061
Proceeds from sale of equity investment		2,450
Payments for acquisitions, net of cash	(500)	(35,331)
Net cash used in investing activities	(3,212)	(38,590)
Cash flows from financing activities
Proceeds from bridge notes, net of debt costs	8,000	34,728
Payments of long-term debt		(5,928)
Proceeds, net of repayments, under line of credit	5,517	2,104
Proceeds from common stock public offering, net of offering costs	11,500	32,058
Payments of issuance costs from common stock public offering	(167)	(1,568)
Payments of debt issuance costs	(457)
Proceeds from exercise of common stock options		95
Payment of deferred cash payment	(75)	(453)
Payment for taxes related to common stock withheld for taxes	(1,423)	(4,468)
Payment of restricted stock liabilities		(2,152)
Net cash provided by financing activities	22,895	54,416
Net (decrease) increase in cash, cash equivalents, and restricted cash	(5,089)	4,522
Cash, cash equivalents, and restricted cash – beginning of year	14,373	9,851
Cash, cash equivalents, and restricted cash – end of year	9,284	14,373
Cash, cash equivalents, and restricted cash
Cash and cash equivalents	9,284	13,871
Restricted cash		502
Total cash, cash equivalents, and restricted cash	9,284	14,373
Supplemental disclosure of cash flow information
Cash paid for interest	12,101	9,528
Cash paid for income taxes	85
Noncash investing and financing activities
Reclassification of stock-based compensation to platform development	1,016	1,884
Debt costs recorded in accrued expenses and other and in other long-term liabilities	189	441
Issuance of common stock upon conversion of Series H convertible preferred stock	13,008	511
Issuance of common stock in connection with settlement of liquidated damages	499	7,008
Issuance of common stock in connection with an acquisition	2,000	3,141
Deferred cash payments recorded in connection with acquisitions	246	949
Assumption of liabilities in connection with acquisitions	1,246	17,110
Reclassification to liability upon common stock modification	$ 68